Publication | Closed Access
ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway
43
Citations
41
References
2019
Year
Solid TumorsMedicineSelective Lsd1 InhibitorDdit4/mtor PathwayCancer BiologyAnti-cancer AgentTumor SuppressorPharmacologyCell BiologyCancer ResearchTumor BiologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1